MedPath

Support Program for Adoption of Cancer Screening Interventions at a Rural Community-Based Organization

Not Applicable
Completed
Conditions
Colorectal Carcinoma
Breast Carcinoma
Cervical Carcinoma
Malignant Solid Neoplasm
Interventions
Other: Training
Other: Cancer Screening intervention
Other: Survey Administration
Registration Number
NCT04208724
Lead Sponsor
Fred Hutchinson Cancer Center
Brief Summary

This pilot trial study uses a structural support program for adoption of cancer screening interventions at a rural community-based organization. Rural communities face unique barriers in implementation of evidence-based interventions due to a lack of infrastructure, community capacity, and expertise as academic and research centers are often clustered in urban areas. The support program may help a rural community-based organization select, adapt, and implement cancer prevention and control evidence-based interventions.

Detailed Description

OUTLINE:

Community-based organizations participate in the support program, consisting of 2 half-day training workshops over 2 weeks, and 30-minute bi-weekly consultations in order to adapt and implement the cancer screening intervention for community members.

After completion of study, participants are followed up at 3 months.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
35
Inclusion Criteria
  • Objective II COMMUNITY-BASED ORGANIZATION: Located in the Yakima Valley of Washington State

  • Objective II COMMUNITY-BASED ORGANIZATION: Serve community members who are 18 and older

  • Objective II COMMUNITY-BASED ORGANIZATION: Willing to commit to the 6-month program

  • Objective II PARTICIPANTS: Receiving services from the recruited community-based organization

  • Objective III PARTICIPANTS: Not up-to-date for breast, cervical, and colorectal cancer screening according to current U.S. Preventive Services Tasks Force (USPSTF) guidelines. The current USPSTF recommendations for breast, cervical, and colorectal cancer are:

    • Breast Cancer Screening: Women ages 50-74 should be screened for breast cancer with mammography every 2 years.
    • Cervical Cancer Screening: Women ages 21-29 should be screened for cervical cancer every 3 years with cervical cancer cytology alone. For women ages 30-65, the USPSTF recommends screening every 3 years with cervical cytology alone, every 5 years or every 5 years with high risk human papillomavirus (hrHPV) testing in combination of cytology.
    • Colorectal Cancer Screening: Individuals ages 50-75 should be screened for colorectal cancer with guaiac-based fecal occult blood tests (gFOBT) or fecal immunochemical test (FIT) once a year, or colonoscopy every 10 years (USPSTF approves additional screening tests, but these are the most commonly used).
  • Objective III PARTICIPANTS: If the community-based organization selects breast cancer screening, we will recruit women ages 50-74.

  • Objective III PARTICIPANTS: If the community-based organization selects cervical cancer screening, we will recruit women ages 21-65.

  • Objective III PARTICIPANTS: If the community-based organization selects colorectal cancer screening, we will recruit women and men ages 50-75.

  • Objective III PARTICIPANTS: Average risk for breast, cervical, or colorectal cancer

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Training programCancer Screening interventionCommunity-based organizations participate in the support program, consisting of 2 half-day training workshops over 2 weeks, and 30-minute bi-weekly consultations in order to adapt and implement the cancer screening intervention for community members.
Training programTrainingCommunity-based organizations participate in the support program, consisting of 2 half-day training workshops over 2 weeks, and 30-minute bi-weekly consultations in order to adapt and implement the cancer screening intervention for community members.
Training programSurvey AdministrationCommunity-based organizations participate in the support program, consisting of 2 half-day training workshops over 2 weeks, and 30-minute bi-weekly consultations in order to adapt and implement the cancer screening intervention for community members.
Primary Outcome Measures
NameTimeMethod
Develop the structural program3 months

Development of the structural training program and accompanying tools

Implementation Monitoring4 months

Implementation of the evidence-based intervention by the community-based organization including 1) dosage (how many interventions were delivered to the participants), 2) types (for which cancer), 3) length of exposure (for how long), and 4) who is involved in the implementation (by whom).

Intention to get screened for cancer (type of cancer will be determined by the community-based organization) pre- and post-interventionUp to 3 months

Difference in the proportion of intention to get screened for cancer pre- and post-intervention using chi-square analyses

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Fred Hutch/University of Washington Cancer Consortium

🇺🇸

Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath